Genes,DisGeNET_Term,DisGeNET_Pvalue_Adjusted,GeDiPNet_Term,GeDiPNet_Pvalue_Adjusted,Orphanet_Term,Orphanet_Pvalue_Adjusted,Virus_Host_Term,Virus_Host_Pvalue_Adjusted,Host organism(s)_Intact,Confidence value(s)_Intact,Taxid interactor A_Intact,Taxid interactor B_Intact
AANAT,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
ABCB1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
ABCC2,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191,,,,,,
ACSL5,Colorectal Carcinoma,0.0034602840073026,,,,,,,In vitro,0.35,chemical synthesis,Homo sapiens
ACTA2,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens HEK293 embryonic kidney cell;In vitro;yeasx,0.35;0.37,Dengue virus 2;Homo sapiens;chemical synthesis;hhv11,Homo sapiens;Yersinia pestis
ADAM15,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,yeasx,0.37,Homo sapiens,Bacillus anthracis
ADAMTS14,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
ADAMTS15,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,"SIX2-related frontonasal dysplasia ORPHA:488437; Peters anomaly ORPHA:708; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584",0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191,,,,,,
AFAP1L2,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
AMOTL2,,,,,"Atrial septal defect, ostium primum type ORPHA:99106; Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; SIX2-related frontonasal dysplasia ORPHA:488437; Auriculocondylar syndrome ORPHA:137888; Peters anomaly ORPHA:708; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; Severe generalized junctional epidermolysis bullosa ORPHA:79404; 20p12.3 microdeletion syndrome ORPHA:261295; Chondrosarcoma ORPHA:55880; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Greig cephalopolysyndactyly syndrome ORPHA:380; Isolated hyperchlorhidrosis ORPHA:542657; Kindler epidermolysis bullosa ORPHA:2908; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Ulnar-mammary syndrome ORPHA:3138; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Branchiootic syndrome ORPHA:52429; Myelodysplastic syndrome ORPHA:52688; Papillary renal cell carcinoma ORPHA:319298; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289; Rieger anomaly ORPHA:91483; Brachydactyly type A2 ORPHA:93396; Unverricht-Lundborg disease ORPHA:308; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0083744975290613; 0.0092060390928213,,,yeasx,0.37;0.56,Homo sapiens,Homo sapiens;Saccharomyces cerevisiae
APOBEC3B,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
B3GLCT,,,Anomalous Pulmonary Artery,0.0075861267486594,,,,,,,,
BBC3,Colorectal Carcinoma; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
BMF,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
C1QL1,Breast Carcinoma,0.0042545616049287,,,,,,,Homo sapiens A549 lung carcinoma cell,0.35,Human SARS coronavirus;SARS-CoV-2,Homo sapiens
CA11,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
CA2,Breast Carcinoma,0.0042545616049287,,,,,,,yeasx,0.37,Homo sapiens,coxbu
CASP7,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,In vitro,0.4;0.44,Homo sapiens;chemical synthesis,Homo sapiens
CCND1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Auriculocondylar syndrome ORPHA:137888; Chondrosarcoma ORPHA:55880; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Isolated hyperchlorhidrosis ORPHA:542657; Kindler epidermolysis bullosa ORPHA:2908; Ulnar-mammary syndrome ORPHA:3138; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Rieger anomaly ORPHA:91483; Unverricht-Lundborg disease ORPHA:308,0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613,,,,,,
CEACAM19,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
CENPE,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,,,,
CHST11,Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
CLSPN,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,,,,
CNTNAP1,Breast Carcinoma,0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens,0.35,Human papillomavirus type 11;Human papillomavirus type 6b;ebvb9,Homo sapiens
COL12A1,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,"Atrial septal defect, ostium primum type ORPHA:99106; Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; SIX2-related frontonasal dysplasia ORPHA:488437; Auriculocondylar syndrome ORPHA:137888; Peters anomaly ORPHA:708; Familial porencephaly ORPHA:99810; Severe generalized junctional epidermolysis bullosa ORPHA:79404; 20p12.3 microdeletion syndrome ORPHA:261295; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Chondrosarcoma ORPHA:55880; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Greig cephalopolysyndactyly syndrome ORPHA:380; Isolated hyperchlorhidrosis ORPHA:542657; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Ulnar-mammary syndrome ORPHA:3138; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Congenital short bowel syndrome ORPHA:2301; Myelodysplastic syndrome ORPHA:52688; Papillary renal cell carcinoma ORPHA:319298; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289; Rieger anomaly ORPHA:91483; Brachydactyly type A2 ORPHA:93396; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0092060390928213,,,yeasx,0.37,Homo sapiens;Yersinia pestis,Bacillus anthracis;Homo sapiens;den27
COL5A2,Colorectal Carcinoma,0.0034602840073026,,,"Atrial septal defect, ostium primum type ORPHA:99106; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; 20p12.3 microdeletion syndrome ORPHA:261295; Chondrosarcoma ORPHA:55880; Greig cephalopolysyndactyly syndrome ORPHA:380; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Tibial hemimelia ORPHA:93322; Congenital short bowel syndrome ORPHA:2301; Brachydactyly type A2 ORPHA:93396",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613,,,In vitro,0.35,chemical synthesis,Homo sapiens
CORO1A,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens HepaRG hepatoma cell;yeasx,0.35;0.37,Hepatitis delta virus;Homo sapiens,Homo sapiens;Yersinia pestis
CPA4,,,,,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.00518481975049,,,In vitro,0.62,Sabellastarte magnifica,Homo sapiens
CPEB4,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Xenopus laevis,0.4,Homo sapiens,Homo sapiens
CTSD,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens QGY7703 hepatocellular carcinoma cell;In vitro;yeasx,0.35;0.37;0.44;0.56,Homo sapiens;Yersinia pestis;canen;chemical synthesis,Homo sapiens;chemical synthesis
CYP24A1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191,,,,,,
CYP4F2,Ovarian Carcinoma,0.0034602840073026,,,,,,,yeasx,0.56,Homo sapiens,Homo sapiens
DEPDC1B,,,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,,,,
DOCK11,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
E2F7,Breast Carcinoma,0.0042545616049287,,,,,,,Homo sapiens U2OS osteosarcoma cell;In vitro,0.35;0.54,Homo sapiens,Homo sapiens
EFR3B,Breast Carcinoma,0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
EHF,Ovarian Carcinoma,0.0034602840073026,,,Severe generalized junctional epidermolysis bullosa ORPHA:79404; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,In vitro,0.54,Homo sapiens,Homo sapiens
ENC1,Colorectal Carcinoma; Mammary Neoplasms,0.0034602840073026; 0.0034602840073026,,,,,,,,,,
ENG,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Anomalous Pulmonary Artery,0.0075861267486594,,,,,Homo sapiens;Homo sapiens HEK293 embryonic kidney cell;Homo sapiens HeLa S3 epitheloid cervical carcinoma cell;yeasx,0.35;0.37;0.4;0.5,Bacillus anthracis;Homo sapiens;Human papillomavirus type 11;Human papillomavirus type 6b;ade05;chemical synthesis;ebvb9,Homo sapiens
ESCO2,,,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,,,,
FAM111B,,,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,yeasx,0.56,Homo sapiens,Homo sapiens
FGF19,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
FHIT,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,In vitro;yeasx,0.95,Homo sapiens,Homo sapiens
FZD1,Breast Carcinoma,0.0042545616049287,,,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613,,,,,,
GAL,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
GLI2,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,"SIX2-related frontonasal dysplasia ORPHA:488437; Peters anomaly ORPHA:708; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; Greig cephalopolysyndactyly syndrome ORPHA:380; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Branchiootic syndrome ORPHA:52429; Congenital short bowel syndrome ORPHA:2301; Rieger anomaly ORPHA:91483",0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,,,,
GPNMB,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
GRAMD1B,,,Breast Carcinoma,0.0075861267486594,,,,,,,,
H2AX,,,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens;Homo sapiens CACO2 Caucasian colon adenocarcinoma cell;Homo sapiens HEK293T embryonic kidney cell;Homo sapiens SW480 adenocarcinoma cell;In vitro,0.35;0.4;0.46,Homo sapiens;SARS-CoV-2,Homo sapiens
HPSE,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens diploid fibroblast;In vitro,0.35;0.4;0.44,chemical synthesis,Homo sapiens
HTATIP2,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens A549 lung carcinoma cell,0.35,Human SARS coronavirus;SARS-CoV-2,Homo sapiens
HYAL1,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
ICA1,Colorectal Carcinoma,0.0034602840073026,,,,,,,yeasx,0.37,Bacillus anthracis,Homo sapiens
ID2,Ovarian Carcinoma,0.0034602840073026,,,,,,,Homo sapiens;yeasx,0.4;0.55;0.56,Homo sapiens;Saccharomyces cerevisiae,Homo sapiens;Saccharomyces cerevisiae
IL22RA1,Colorectal Carcinoma,0.0034602840073026,,,Severe generalized junctional epidermolysis bullosa ORPHA:79404; Kindler epidermolysis bullosa ORPHA:2908; Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,,,,
IQGAP2,Ovarian Carcinoma,0.0034602840073026,,,,,,,In vitro;yeasx,0.35;0.37;0.46,Bacillus anthracis;Homo sapiens;chemical synthesis,Homo sapiens;ebvg;hcvjf
ISL1,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
ITGA2,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Auriculocondylar syndrome ORPHA:137888; Severe generalized junctional epidermolysis bullosa ORPHA:79404; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Isolated hyperchlorhidrosis ORPHA:542657; Kindler epidermolysis bullosa ORPHA:2908; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Myelodysplastic syndrome ORPHA:52688; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,In vitro;ecoli;yeasx,0.35;0.37;0.44;0.56;0.59,Homo sapiens;Mus musculus;chemical synthesis;chick;rat;rots1,Echis multisquamatus;Homo sapiens;Mus musculus;bovin;coxbu
KAT2B,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens CD4+ T-cell;Homo sapiens HeLa epitheloid cervical carcinoma cell;Homo sapiens LNCaP caucasian prostate adenocarcinoma cell;Homo sapiens M059JK glioblastoma cell;Homo sapiens U2OS osteosarcoma cell;In vitro;Saccharomyces cerevisiae,0.35;0.4;0.44;0.51;0.66,Homo sapiens;ade05,-;Homo sapiens;ade05;chemical synthesis
KCNN4,Breast Carcinoma,0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
KITLG,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Anomalous Pulmonary Artery,0.0075861267486594,"Atrial septal defect, ostium primum type ORPHA:99106; Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; SIX2-related frontonasal dysplasia ORPHA:488437; Auriculocondylar syndrome ORPHA:137888; Peters anomaly ORPHA:708; 20p12.3 microdeletion syndrome ORPHA:261295; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Isolated hyperchlorhidrosis ORPHA:542657; Kindler epidermolysis bullosa ORPHA:2908; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Ulnar-mammary syndrome ORPHA:3138; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Papillary renal cell carcinoma ORPHA:319298; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289; Rieger anomaly ORPHA:91483; Brachydactyly type A2 ORPHA:93396; Unverricht-Lundborg disease ORPHA:308; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0083744975290613; 0.0092060390928213,,,In vitro,0.44,Homo sapiens,Homo sapiens
KRT13,Breast Carcinoma,0.0042545616049287,,,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191,,,In vitro;yeasx,0.35;0.56,Homo sapiens;chemical synthesis,Homo sapiens
KRT23,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
LAMA3,Mammary Neoplasms; Ovarian Carcinoma,0.0034602840073026; 0.0034602840073026,,,"Atrial septal defect, ostium primum type ORPHA:99106; Autosomal recessive nail dysplasia ORPHA:280654; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Severe generalized junctional epidermolysis bullosa ORPHA:79404; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Isolated hyperchlorhidrosis ORPHA:542657; Kindler epidermolysis bullosa ORPHA:2908; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Myelodysplastic syndrome ORPHA:52688; Papillary renal cell carcinoma ORPHA:319298; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,Homo sapiens;Homo sapiens HEK293 embryonic kidney cell,0.35;0.4,Homo sapiens;ebvb9,Homo sapiens
LAMP3,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens HEK293T embryonic kidney cell,0.35,Homo sapiens,Homo sapiens
LIFR,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594,"Atrial septal defect, ostium primum type ORPHA:99106; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Greig cephalopolysyndactyly syndrome ORPHA:380; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Ulnar-mammary syndrome ORPHA:3138; Branchiootic syndrome ORPHA:52429; Myelodysplastic syndrome ORPHA:52688; Brachydactyly type A2 ORPHA:93396; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0092060390928213,,,Homo sapiens,0.35,ebvb9,Homo sapiens
LRIG1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
LZTS1,Colorectal Carcinoma; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
ME1,Breast Carcinoma,0.0042545616049287,,,Papillary renal cell carcinoma ORPHA:319298; Unverricht-Lundborg disease ORPHA:308,0.0083045131203191; 0.0083744975290613,,,In vitro;yeasx,0.35;0.68,Homo sapiens,Homo sapiens;chemical synthesis
MICB,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
MIR100HG,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
MIR17HG,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
MKNK2,Breast Carcinoma,0.0042545616049287,,,,,,,yeasx,0.37,Homo sapiens,Homo sapiens
MT1E,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049,,,,,,
NEU1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens HEK293T embryonic kidney cell;In vitro,0.35;0.53,Homo sapiens;SARS-CoV-2;chemical synthesis,Homo sapiens
NGFR,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
NOLC1,Colorectal Carcinoma; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens CACO2 Caucasian colon adenocarcinoma cell;In vitro,0.35,SARS-CoV-2;chemical synthesis,Homo sapiens
NR4A2,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,yeasx,0.37,Homo sapiens,Homo sapiens
NRIP1,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Congenital Anomalies Of Kidney And Urinary Tract; Breast Carcinoma,0.0075861267486594; 0.0075861267486594,,,,,,,,
OGFR,Ovarian Carcinoma,0.0034602840073026,,,,,,,,,,
OIP5,Breast Carcinoma,0.0042545616049287,,,,,,,Homo sapiens HEK293T embryonic kidney cell;Saccharomyces cerevisiae;yeasx,0.35;0.56;0.67,Homo sapiens,Homo sapiens
P2RX7,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
P3H2,Breast Carcinoma,0.0042545616049287,,,20p12.3 microdeletion syndrome ORPHA:261295,0.0083045131203191,,,yeasx,0.37,Bacillus anthracis;Homo sapiens,Bacillus anthracis;Homo sapiens
PADI3,,,,,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191,,,yeasx,0.67,Homo sapiens,Homo sapiens
PBX1,Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594,,,,,,,,
PCDH7,,,,,"Atrial septal defect, ostium primum type ORPHA:99106; Peters anomaly ORPHA:708; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146; Greig cephalopolysyndactyly syndrome ORPHA:380; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Branchiootic syndrome ORPHA:52429; Brachydactyly type A2 ORPHA:93396; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0092060390928213,,,,,,
PDE4B,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
PDGFB,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Escherichia coli;Homo sapiens HEK293T embryonic kidney cell;In vitro,0.35;0.73,Homo sapiens,Homo sapiens
PLEKHD1,,,Breast Carcinoma,0.0075861267486594,,,,,,,,
PLK2,Ovarian Carcinoma,0.0034602840073026,,,Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Auriculocondylar syndrome ORPHA:137888; Chondrosarcoma ORPHA:55880; Familial progressive hyper- and hypopigmentation ORPHA:280628; Familial progressive hyperpigmentation ORPHA:79146,0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,Homo sapiens HeLa epitheloid cervical carcinoma cell,0.4,Homo sapiens,Mus musculus
PLSCR4,,,,,"Atrial septal defect, ostium primum type ORPHA:99106; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; 20p12.3 microdeletion syndrome ORPHA:261295; Papillary renal cell carcinoma ORPHA:319298; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0092060390928213,,,yeasx,0.37;0.56,Bacillus anthracis;Homo sapiens,Homo sapiens
PRMT6,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens HEK293T embryonic kidney cell;In vitro;yeasx,0.35;0.52;0.56,Homo sapiens;hhv8,Homo sapiens;chemical synthesis
PRR15,Colorectal Carcinoma,0.0034602840073026,,,,,,,In vitro;yeasx,0.35;0.44;0.56,HCV77;Homo sapiens;chemical synthesis,Homo sapiens
PRSS23,Breast Carcinoma,0.0042545616049287,,,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118; Auriculocondylar syndrome ORPHA:137888; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191,,,,,,
PURPL,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
RBM24,,,,,"Atrial septal defect, ostium secundum type ORPHA:99103; Branchiootic syndrome ORPHA:52429",0.00518481975049; 0.0083045131203191,,,,,,
RGL1,,,,,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome ORPHA:79118,0.00518481975049,,,,,,
RGS6,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,,,,
RHOBTB3,,,,,Myelodysplastic syndrome ORPHA:52688,0.0083045131203191,,,In vitro,0.44,Homo sapiens;chemical synthesis,Homo sapiens;chemical synthesis
RHOU,Mammary Neoplasms,0.0034602840073026,,,,,,,In vitro,0.44,Homo sapiens,chemical synthesis
RPSAP52,,,,,Arnold-Chiari malformation type I ORPHA:268882,0.00518481975049,,,,,,
RTKN2,Breast Carcinoma,0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,,,,
S100A14,Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,Severe generalized junctional epidermolysis bullosa ORPHA:79404; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Kindler epidermolysis bullosa ORPHA:2908; Laryngo-onycho-cutaneous syndrome ORPHA:2407; Autosomal recessive infantile hypercalcemia ORPHA:300547,0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,,,,
SETD7,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,In vitro,0.44,Homo sapiens,-;chemical synthesis
SHCBP1,,,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,Homo sapiens HeLa epitheloid cervical carcinoma cell,0.4,Mus musculus,Homo sapiens
SIX2,Breast Carcinoma,0.0042545616049287,Congenital Anomalies Of Kidney And Urinary Tract,0.0075861267486594,SIX2-related frontonasal dysplasia ORPHA:488437; Peters anomaly ORPHA:708; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Branchiootic syndrome ORPHA:52429; Rieger anomaly ORPHA:91483,0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,Homo sapiens HEK293T embryonic kidney cell;yeasx,0.37;0.4,Homo sapiens,Homo sapiens
SKAP1,Ovarian Carcinoma,0.0034602840073026,,,,,,,,,,
SLC22A18,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens;In vitro,0.35,Homo sapiens;Human papillomavirus type 11;Human papillomavirus type 6b;ebvb9,Homo sapiens
SMAD6,Ovarian Carcinoma,0.0034602840073026,,,"Atrial septal defect, ostium secundum type ORPHA:99103; Ulnar-mammary syndrome ORPHA:3138; Myelodysplastic syndrome ORPHA:52688; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289",0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,Chlorocebus aethiops;Homo sapiens;Homo sapiens HEK293T embryonic kidney cell;Saccharomyces cerevisiae,0.35;0.4;0.51,Homo sapiens;Mus musculus,Homo sapiens
SMAD7,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens,0.4,Homo sapiens,Homo sapiens
SNAI2,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Anomalous Pulmonary Artery; Breast Carcinoma,0.0075861267486594; 0.0075861267486594,"Atrial septal defect, ostium primum type ORPHA:99106; Arnold-Chiari malformation type I ORPHA:268882; Autosomal recessive nail dysplasia ORPHA:280654; Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; SIX2-related frontonasal dysplasia ORPHA:488437; Peters anomaly ORPHA:708; Atrial septal defect, ostium secundum type ORPHA:99103; Familial porencephaly ORPHA:99810; 20p12.3 microdeletion syndrome ORPHA:261295; Chondrosarcoma ORPHA:55880; Greig cephalopolysyndactyly syndrome ORPHA:380; Isolated hyperchlorhidrosis ORPHA:542657; Pallister-Hall syndrome ORPHA:672; Polysyndactyly ORPHA:93338; Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584; Sensorineural deafness with dilated cardiomyopathy ORPHA:217622; Tibial hemimelia ORPHA:93322; Ulnar-mammary syndrome ORPHA:3138; Axenfeld anomaly ORPHA:98978; Axenfeld-Rieger syndrome ORPHA:782; Branchiootic syndrome ORPHA:52429; Congenital short bowel syndrome ORPHA:2301; Papillary renal cell carcinoma ORPHA:319298; Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289; Rieger anomaly ORPHA:91483; Brachydactyly type A2 ORPHA:93396; Unverricht-Lundborg disease ORPHA:308; Waardenburg syndrome type 2 ORPHA:895",0.0040361447187818; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191; 0.0083744975290613; 0.0083744975290613; 0.0092060390928213,,,Homo sapiens MDA-MB-468 mammary gland adenocarcinoma cell,0.35,Homo sapiens,Homo sapiens
SNCG,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens HEK293 embryonic kidney cell,0.4,Homo sapiens,Homo sapiens
SORBS1,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,In vitro;chinese hamster ovary cell line,0.35;0.4,Homo sapiens;chemical synthesis;crigr,Homo sapiens;Mycobacterium tuberculosis (strain ATCC 35801 / TMC 107 / Erdman)
SORT1,Colorectal Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens;Homo sapiens A549 lung carcinoma cell;In vitro,0.35;0.4;0.44;0.56;0.68,Homo sapiens;Human SARS coronavirus;SARS-CoV-2;ade05;chemical synthesis;ebvb9,Homo sapiens;chemical synthesis
SPC25,,,,,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.0083045131203191,,,In vitro,0.35,chemical synthesis,Homo sapiens
STN1,Colorectal Carcinoma,0.0034602840073026,,,,,,,,,,
SULT1A1,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,Homo sapiens HEK293T embryonic kidney cell;yeasx,0.35;0.37,Homo sapiens,Bacillus anthracis;Homo sapiens
SUSD4,Breast Carcinoma,0.0042545616049287,,,,,,,,,,
TET1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,,,,
TFAP4,Colorectal Carcinoma,0.0034602840073026,,,,,,,Homo sapiens HCT116 colon carcinoma cell;In vitro;yeasx,0.35;0.37;0.58,Homo sapiens,Homo sapiens
TGM2,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.00518481975049,,,Homo sapiens HLMVEC lung microvascular endothelial cell;In vitro;yeasx,0.35;0.37;0.44;0.76,Homo sapiens;chemical synthesis,Homo sapiens;chemical synthesis
THBS1,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601; Auriculocondylar syndrome ORPHA:137888; Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960; Chondrosarcoma ORPHA:55880; Congenital short bowel syndrome ORPHA:2301,0.00518481975049; 0.00518481975049; 0.0083045131203191; 0.0083045131203191; 0.0083045131203191,,,Homo sapiens HLMVEC lung microvascular endothelial cell;Homo sapiens blood plasma;In vitro;Saccharomyces cerevisiae,0.35;0.37;0.44;0.61;0.7,Homo sapiens;chemical synthesis;staa8,Homo sapiens;chemical synthesis;hcvco
TIMP2,Colorectal Carcinoma; Mammary Neoplasms; Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,Unverricht-Lundborg disease ORPHA:308,0.0083744975290613,,,Homo sapiens HEK293 embryonic kidney cell,0.4,Homo sapiens,Homo sapiens
TNFSF9,Colorectal Carcinoma; Ovarian Carcinoma,0.0034602840073026; 0.0034602840073026,,,,,,,Homo sapiens A549 lung carcinoma cell,0.35,Human SARS coronavirus;SARS-CoV-2,Homo sapiens
TPM4,,,,,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191,,,In vitro;yeasx,0.35;0.49,Homo sapiens;chemical synthesis,Homo sapiens;hcvjf
TRAK2,Breast Carcinoma,0.0042545616049287,Breast Carcinoma,0.0075861267486594,,,,,yeasx,0.37,Homo sapiens,Yersinia pestis
TRIB3,Colorectal Carcinoma; Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0034602840073026; 0.0042545616049287,,,,,,,yeasx,0.56,Homo sapiens,Homo sapiens
TSC22D1,Mammary Neoplasms,0.0034602840073026,,,,,,,Homo sapiens HEK293 embryonic kidney cell;Homo sapiens HEK293flp-in T-REX embryonic kidney cell;In vitro;Saccharomyces cerevisiae;yeasx,0.4;0.46;0.55,Homo sapiens,Homo sapiens
VGLL3,Ovarian Carcinoma; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,Breast Carcinoma,0.0075861267486594,Congenital short bowel syndrome ORPHA:2301,0.0083045131203191,,,Homo sapiens HEK293T embryonic kidney cell;yeasx,0.56;0.6,Homo sapiens,Homo sapiens
WNT16,Mammary Neoplasms,0.0034602840073026,,,,,,,,,,
WNT9A,Mammary Neoplasms,0.0034602840073026,,,SIX2-related frontonasal dysplasia ORPHA:488437,0.00518481975049,,,,,,
ZNF703,Mammary Neoplasms; Breast Carcinoma,0.0034602840073026; 0.0042545616049287,,,,,,,Homo sapiens HEK293T embryonic kidney cell,0.35,Homo sapiens,Homo sapiens
